Olema Pharmaceuticals Newsroom

Express News | Form 144 | Olema Pharmaceuticals(OLMA.US) Insider Proposes to Sell 4.73 Million in Common Stocks

Moomoo NewsDec 13 16:42 ET

Olema Pharmaceuticals Down Over 19%, on Pace for Largest Percent Decrease Since August 2022 -- Data Talk

Dow JonesDec 12 14:14 ET

Insider Sale: Director at $OLMA (OLMA) Sells 8,256 Shares

Quiver QuantitativeDec 11 20:01 ET

Express News | Bain Capital Life Sciences Opportunities IV, L.p. Reports 9.99% Passive Stake in Olema Pharmaceuticals Inc as of Dec 4 - SEC Filing

ReutersDec 11 16:35 ET

Oppenheimer Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsDec 11 08:31 ET · Ratings

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

TipRanksDec 11 07:46 ET · Ratings

TD Cowen Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating

Moomoo NewsDec 11 07:31 ET · Ratings

TD Cowen Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)

TipRanksDec 11 07:25 ET · Ratings

H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsDec 11 06:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

BenzingaDec 11 06:27 ET

Olema Pharmaceuticals Analyst Ratings

BenzingaDec 11 06:26 ET · Ratings

Olema Pharmaceuticals: Promising Clinical Data and Growth Potential Warrant a Buy Rating

TipRanksDec 11 06:17 ET · Ratings

Express News | Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium

ReutersDec 10 07:00 ET

Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate

MT NewswiresDec 9 09:40 ET

Express News | Olema Pharmaceuticals Shares Are Trading Higher After the Company Announced the FDA Cleared the Investigational New Drug (IND) Application for OP-3136

BenzingaDec 9 08:10 ET

Olema Pharmaceuticals Shares Rise 8.9% on FDA Approval of Cancer Drug Application

WSJDec 9 07:52 ET

Olema Pharmaceuticals Announces FDA Clearance for OP-3136 IND Application, Phase 1 Clinical Trial Set to Begin in Early 2025

Quiver QuantitativeDec 9 07:12 ET

Express News | Olema Pharmaceuticals Inc - Phase 1 Clinical Trial for Op-3136 to Start Early 2025

ReutersDec 9 07:00 ET

Express News | Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor

ReutersDec 9 07:00 ET

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor

GlobeNewswireDec 9 07:00 ET